Abstract
Stem cell research remains a tremendously promising yet controversial field of study. It continues to attract considerable public interest and generate discussion and debate. However, while the high profile of this field has endured, the tone and nature of the discourse that drives this profile appears to be changing. In order to get a better sense of how these potential shifts are perceived by individuals directly embedded in the field, we conducted an international internet survey of members of the stem cell research community. Our participants included individuals publishing on both scientific and ethical, legal and social issues topics. We explored the degree to which participants perceived that key policy issues were becoming more or less contentious over time. We queried views regarding the effect of regulatory frameworks on emerging stem cell research technologies and the extent to which participants experience pressure related to clinical translation. We also explored participants’ relationships with industry, experience with patents and perceptions regarding the emphasis placed on the potential economic benefits of stem cell research. Our results suggest that while traditional debates such as those surrounding the moral status of the embryo remain, other issues more closely associated with clinical translation and commercialization are perceived as becoming increasingly contentious. This survey provides useful insight into the perspectives of a sample of active researchers working in countries around the world as well as an opportunity to reflect on the likely direction of future stem cell policy debates.
Similar content being viewed by others
Notes
The Web of Science is a leading international citation database with multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, arts and humanities.
Participants who indicated that they conducted both scientific and ELSI research are classified as scientists where comparisons between scientists and ELSI researchers are included.
CIRM’s mission is to “support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury” (CIRM).
References
Neate, R. (2 Oct 2011). Stem cell centre gets green light from UK government. The Guardian. http://www.guardian.co.uk/business/2011/oct/02/stem-cell-centre-government-investment. Accessed 15 June 2012.
Caulfield, T. (2010). Stem cell research and economic promises. The Journal of Law, Medicine & Ethics, 38, 303–313.
Hyun, I. (2010). The bioethics of stem cell research and therapy. The Journal of Clinical Investigation, 120(1), 71–75.
Blendon, R., Kim, M. K., & Benson, J. (2011). The public, political parties, and stem-cell research. The New England Journal of Medicine, 365(20), 1853–1856.
Tumulty, K. (29 Jan 2012). Gingrich vows to ban embryonic stem-cell research, questions in vitro practices. The Washington Post. http://www.washingtonpost.com/politics/gingrich-vows-to-ban-embryonic-stem-cell-research-questions-in-vitro-practices/2012/01/29/gIQAIO9saQ_story.html. Accessed 3 May 2012.
Young, S. (2012). Candidates play to the right on science; rivals for the Republican nomination laud research but take a hard line on embryonic stem cells and climate. Nature, 481, 421–423.
Caulfield, T., & Bubela, T. (2007). Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate. The American Journal of Bioethics, 7(2), 1–11.
Zarzeczny, A., Scott, C., Hyun, I., Bennett, J., Chandler, J., Chargé, S., et al. (2009). iPS cells: mapping the policy issues. Cell, 139(6), 1032–1037.
California Institute of Regenerative Medicine. About CIRM. http://www.cirm.ca.gov/about-cirm. Accessed 3 May 2012.
Zarzeczny, A., & Caulfield, T. (2009). Emerging ethical, legal and social issues associated with stem cell research and the current role of the moral status of the embryo. Stem Cell Reviews and Reports, 5(2), 96–101.
Lovell-badge, R. (2011). Stem cell scientists will simply switch to U.S. if investment cannot be protected. The Daily Mail (United Kingdom). http://www.dailymail.co.uk/news/article-2050737/Stem-cell-scientists-switch-US-investment-protected.html. Accessed 25 July 2012.
Vrtovec, K. T., & Scott, C. T. (2011). The European Court of Justice ruling in Brüstle v. Greenpeace: the impacts on patenting of human induced pluripotent stem cells in Europe. Cell Stem Cell, 9, 502–503.
Little, M., Hall, W., & Orlandi, A. (2006). Delivering on the promise of human stem-cell research: what are the real barriers? EMBO Reports, 7(12), 1188–1192.
Bubela, T., & Caulfield, T. (2010). Role and reality: technology transfer at Canadian universities. Trends in Biotechnology, 28, 447–451.
Lau, D., Ogbogu, U., Taylor, B., Stafinski, T., Menon, D., & Caulfield, T. (2008). Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell, 3, 591–594.
Levine, A. (2010). Stem cell tourism: assessing the state of knowledge. ScriptED, 7(2), 274–282.
Regenberg, A., Hutchinson, L., Schanker, B., & Matthews, D. (2009). Medicine on the fringe: stem cell-based interventions in advance of evidence. Stem Cells, 27, 2312–2319.
Cyranoski, D. (2012). Stem-cell therapy takes off in Texas: a boom in unproven procedures is worrying scientists. Nature, 483, 13–14.
Zarzeczny, A., Rachul, C., Caulfield, T. (2012). The phenomenon of stem cell tourism. In A. Atala (Ed.), Progenitor and stem cell technologies and therapies: Principles and Issues, Vol 1. Philadelphia: Woodhead Publishing.
Cyranoski, D. (2011). Texas prepares to fight for stem cells. Nature, 477, 377–378.
Bubela, T., & Caulfield, T. (2010). Role and reality: technology transfer at Canadian universities. Trends in Biotechnology, 28(9), 447–451.
Caulfield, T., Harmon, S., & Joly, Y. (2012). Open science versus commercialization: a modern research conflict? Genome Medicine, 4, 17.
Acknowledgments
This work was supported in part by Canada’s Stem Cell Network and by the Cancer Stem Cell Consortium, with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047), and through the Canadian Institute of Health Research (CSC-105367). The authors gratefully acknowledge the support of their funders, institutions and project collaborators.
Conflicts of interest
The authors declare no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 27 kb)
Rights and permissions
About this article
Cite this article
Caulfield, T., Rachul, C. & Zarzeczny, A. The Evolution of Policy Issues in Stem Cell Research: An International Survey. Stem Cell Rev and Rep 8, 1037–1042 (2012). https://doi.org/10.1007/s12015-012-9404-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-012-9404-5